Astex Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 70   

Articles published

ASTX 0.0000
price chart
Astex Pharmaceuticals Enters Clinical Trial Collaboration to Explore the ...
PLEASANTON, Calif.--(BUSINESS WIRE)--Astex Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of novel small molecule oncology therapeutics, announced today that it has entered into a clinical collaboration with Genentech.
SuperGen, Inc. Changes Name To Astex Pharmaceuticals, Inc., Announces New ...
SuperGen, Inc. (NASDAQ:ASTX) announced that it has officially begun operating under the name Astex Pharmaceuticals, Inc. Concurrent with this new name, and effective at the start of trading today, September 12, 2011, the ticker symbol for the Company's ...
Pomerantz Announces Notice of Dismissal of Astex Pharmaceuticals, Inc. Class ...
NEW YORK, Nov. 11, 2014 (GLOBE NEWSWIRE) -- By order of the Delaware Court of Chancery dated November 5, 2014, the following notice is being published.
Related articles »  
James Manuso, chairman and CEO of Astex Pharmaceuticals Inc.
Background: Manuso, a self-described “Euro mutt,” joined SuperGen Inc. as a director in 2001 and became chairman and CEO of Astex Pharma after SuperGen's acquisition last summer of Astex Therapeutics Ltd. in the U.K. The 140-employee company has ...
Astex Pharmaceuticals Announces Orphan Drug Designation for Guadecitabine (SGI ...
FDA has granted an orphan drug designation for Astex Pharmaceuticals' investigational drug, guadecitabine (SGI-110), in the treatment of acute myeloid leukemia (AML).
Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in ...
DUBLIN, Calif., July 8, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, announced today its plan to submit an ...
Related articles »  
Astex Pharma and Genentech Forge a Clinical Trial Deal for AML
Financial terms of the deal between the companies were not disclosed. However, Astex said the two companies will collaborate to explore the combination of Astex's next generation hypomethylating agent, guadecitabine (SGI-110), with Genentech's ...
Celgene Corporation (CELG), Cytokinetics, Inc. (CYTK), Astex Pharmaceuticals ...
“Bubble” can be a provocative word in investing circles. Think of all that comes to mind when you hear it - perhaps other words like over-hyped, overvalued, risky, etc.
Related articles »  
5 Reasons To Buy Astex Pharmaceuticals
Astex Pharmaceuticals has established a broad pipeline of small molecule, molecularly-targeted drugs using its drug discovery engine, Pyramid, which is also used to support the company's drug discovery collaborations with leading pharmaceutical company ...
Astex Pharmaceuticals Discontinues Amuvatinib Clinical Development Program
DUBLIN, Calif., Sept. 21, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that clinical development of ...